Want to join the conversation?
$BMY Dividend Update: The BoD of Bristol-Myers Squibb declared a quarterly dividend of $0.50 per share on the $2 Convertible Preferred Stock of the corporation, payable Sept. 1, 2015, to stockholders of record at the close of business on August 7, 2015.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?